| Business Name: |
Costarino Andrew T MD |
| Contact Person: |
Andrew Costarino |
| Address: |
Dupont Hospital For Dna, Wilmington, Delaware 19803 |
| Phone Number: |
(302) 651-5160 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Smith Nadine M DO - Wilmington, DE 19803
Alexander Michael A MD - Wilmington, DE 19803
Bercaw David MD - Wilmington, DE 19803
Campbell Jeffrey W MD - Wilmington, DE 19803
Nadiv Shapira Dr - Wilmington, DE 19803
Estock David S MD - Wilmington, DE 19803
Greenspan Jay S MD - Wilmington, DE 19803
White Krishna MD - Wilmington, DE 19803
Furuya Katryn N MD - Wilmington, DE 19803
Yost Oliver MD - Wilmington, DE 19803
Duffy Brian J MD - Wilmington, DE 19803
Jaradat Lara F MD - Wilmington, DE 19803
Giordano Kathryn M DO - Wilmington, DE 19803
Palmer Kathleen M MD - Wilmington, DE 19803
Walmsley Daniel DO - Wilmington, DE 19803
Datto III George MD - Wilmington, DE 19803
Arai Lynda D MD - Wilmington, DE 19803
Rosen Paul MD - Wilmington, DE 19803
Ierardi Jane A MD - Wilmington, DE 19803
Leafe Morgan E MD - Wilmington, DE 19803
|
The company Costarino Andrew T MD provides B2C services in the form of Doctors from its single location in Delaware.
1 to 4 employees work for Costarino Andrew T MD, and the business now earns $500.000 to $999.999 per annum.
Costarino Andrew T MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Costarino Andrew T MD, please call Andrew Costarino with the phone number (302) 651-5160 or visit its single location at Dupont Hospital For Dna in Wilmington, Delaware 19803.
The location of the single location can also be found using the coordinates 39.79293,-75.53294.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.